Chronic Kidney Disease as an Independent Risk Factor for Thromboembolism in Patients with Atrial Fibrillation |
Oh, Gyu-Chul
(Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine)
Cha, Myung-Jin (Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine) Kang, Do-Yoon (Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine) Kim, Ji-Yeong (Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine) Sung, Young-Jun (Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine) Yoon, Jung-Han (Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine) Lee, Dong-Won (Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine) Lee, Min-Ho (Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine) Choe, Won-Seok (Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine) Choi, Eue-Keun (Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine) Oh, Se-Il (Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine) |
1 | Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001;285:2370-2375. DOI ScienceOn |
2 | Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991;22:983-988. DOI ScienceOn |
3 | Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001;285:2864-2870. DOI ScienceOn |
4 | Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for practice guidelines (Writing Committee to revise the 2001 guidelines for the management of patients with atrial fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006;114:e257-e354. DOI ScienceOn |
5 | Fang MC, Singer DE, Chang Y, et al. Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. Circulation 2005;112:1687-1691. DOI ScienceOn |
6 | Hart RG, Pearce LA, McBride R, Rothbart RM, Asinger RW. Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials: the Stroke Prevention in Atrial Fibrillation (SPAF) Investigators. Stroke 1999;30:1223-1229. DOI ScienceOn |
7 | Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled clinical trials. Arch Intern Med 1994;154:1449-1457. DOI ScienceOn |
8 | van Walraven C, Hart RG, Wells GA, et al. A clinical prediction rule to identify patients with atrial fibrillation and a low risk for stroke while taking aspirin. Arch Intern Med 2003;163:936-943. DOI ScienceOn |
9 | Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010;31:2369-2429. DOI ScienceOn |
10 | Hart RG, Pearce LA, Aguilar MI. Adjusted-dose warfarin versus aspirin for preventing stroke in patients with atrial fibrillation. Ann Intern Med 2007;147:590-592. |
11 | Landefeld CS, Goldman L. Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy. Am J Med 1989;87:144-152. DOI ScienceOn |
12 | Go AS, Fang MC, Udaltsova N, et al. Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. Circulation 2009;119:1363-1369. DOI ScienceOn |
13 | Seliger SL, Longstreth WT Jr, Kestenbaum B, Stehman-Breen CO. Elevated risk of stroke among patients with end-stage renal disease. Kidney Int 2003;64:603-609. DOI ScienceOn |
14 | Levey AS, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003;139:137-147. DOI ScienceOn |
15 | Khella SL. New insights into stroke in chronic kidney disease. Adv Chronic Kidney Dis 2008;15:338-346. DOI ScienceOn |